From July 1, 2023 to September 30, 2023, the company has repurchased 5,851,132 shares, representing 0.31% for CNY 69.76 million. With this, the company has completed the repurchase of 46,513,711 shares, representing 2.44% for CNY 564.25 million under the buyback announced on December 15, 2022.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
12.97 CNY | +0.46% | +3.43% | +4.34% |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+4.34% | 3.35B | |
+29.98% | 682B | |
+32.39% | 586B | |
-3.52% | 364B | |
+18.59% | 327B | |
+4.07% | 285B | |
+16.50% | 240B | |
+9.56% | 209B | |
-9.04% | 203B | |
+7.09% | 165B |
- Stock Market
- Equities
- 600380 Stock
- News Joincare Pharmaceutical Group Industry Co.,Ltd.
- Tranche Update on Joincare Pharmaceutical Group Industry Co.,Ltd.'s Equity Buyback Plan announced on December 15, 2022.